October 10, 2017 / 10:29 AM / 2 months ago

BRIEF-Mithra Pharmaceuticals' application for Tibelia marketing authorization accepted by Health Canada‍​

Oct 10 (Reuters) - MITHRA PHARMACEUTICALS SA:

* MITHRA’S MARKETING AUTHORIZATION APPLICATION FOR TIBELIA ACCEPTED BY HEALTH CANADA‍​

* ‍MITHRA IS ON TRACK TO RECEIVE POTENTIAL TIBELIA® APPROVAL AS OF Q4 2018​

* MITHRA ANNOUNCED AN EXCLUSIVE LICENSE AND SUPPLY AGREEMENT FOR TIBELIA® WITH AN UNDISCLOSED CANADIAN PARTNER

* ‍CANADIAN MENOPAUSAL HEALTH MARKET IS WORTH EUR 80 MILLION WITH GROWTH POTENTIAL, OFFERING OPPORTUNITY FOR TIBELIA

* SEES ‍CANADA AS IMPORTANT CONTRIBUTOR TO GROWING REVENUES FROM TIBELIA​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below